A shadow market for unapproved weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to contact these accounts privately for source information, while also obtaining discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and assertions of next-day British shipping. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering products of uncertain source.
Some experts said the demand for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, legal action or imprisonment.
Platform Reaction and Material Removal
According to TikTok, the service has removed violative material and prohibited related keywords and search suggestions. The organization said it was committed to keeping the platform secure and investing in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with images of weight loss, glowing reviews and step-by-step guides for mixing or injecting at residence.
After minutes of entering one group, a vendor posted contact information, where most purchases occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.
Item Information and Pricing
Within these groups, messages show black plastic parcels with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service said it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they cannot confirm. Although the research behind this drug is sound, these online products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has previously encountered individuals harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly significant medical dangers”.
